Call for Papers

Medical Imaging with Deep Learning (MIDL) 2026

July 8–10, 2026 • Taipei, Taiwan, ROC

The Medical Imaging with Deep Learning (MIDL) Conference is the premier international meeting dedicated to deep learning for biomedical image analysis. It brings together researchers, clinicians, and industry professionals to exchange ideas, present cutting-edge methods, and discuss how artificial intelligence is transforming medical imaging research and clinical practice.

The 2026 edition will be held in person in Taipei, Taiwan, ROC, with free online streaming to ensure global participation. Alongside a vibrant scientific program featuring plenary talks, oral and poster presentations, MIDL 2026 will also include tutorials, challenges, and opportunities for networking across disciplines.

Building on its tradition of fostering both algorithmic innovation and clinical translation, MIDL 2026 invites contributions that range from foundational methodologies to validation studies demonstrating real-world impact.

Topics of Interest

• Segmentation, detection, and classification of medical images
• Learning-based image registration and reconstruction
• Clinical integration, workflow optimization, and real-world deployment
• Self-, semi-, and unsupervised representation learning
• Transfer learning, domain adaptation, and learning with limited or noisy labels
• Generative AI and diffusion models for imaging
• Foundation and large vision–language models for healthcare
• Multimodal learning combining imaging with text, omics, sensors, or clinical data
• Uncertainty estimation, calibration, and interpretability
• Federated, distributed, and privacy-preserving learning
• Safe, trustworthy, and responsible AI solutions
• Robust validation and benchmarking across radiology, pathology, endoscopy, dermatology, ophthalmology, and beyond

Inquiries to the program chairs can be addressed directly to [email protected].

Submission Guidelines

MIDL 2026 offers two full-paper tracks and a short-paper track:

Conference submissions follow two tracks: full conference papers and short papers.

• Main Track – Methodological Development: New algorithms, architectures, or models for medical imaging. Up to 10 pages (excluding references) at submission; up to 12 pages after rebuttal.
• Special Track – Validation Studies: A new track dedicated to large-scale or clinically oriented validation of deep learning methods. Up to 14 pages (excluding references) for submission and camera-ready. up to 16 pages after rebuttal.

All papers must use the official MIDL LaTeX template. and be submitted via OpenReview. Reviews are single-blind, which means reviewers know the authors’ identities, but authors do not know the reviewers’.. Papers must be original and not under review elsewhere.

Short Papers (≤ 3 pages, excluding references) may present early ideas or discuss recent/submitted journal work. Accepted short papers will be presented as posters or spotlights.

For inquiries, please contact the program chairs at [email protected].

Validation Studies (Special Track)

NEW for MIDL 2026: The Validation Studies track debuts this year, offering a dedicated venue for rigorously evaluated deep learning methods in biomedical imaging, with an emphasis on robustness, reproducibility, and translational relevance.

Submissions should showcase well-designed experiments, external validations, and evidence of generalization across datasets, institutions, or patient populations.

Scope includes multi-center or multi-site evaluations, fairness, reliability, and robustness studies, head-to-head algorithm comparisons, clinical utility assessments, prospective/retrospective studies, observer studies, or workflow integration, as well as systematic reviews or meta-analyses that provide new insights into translational challenges.

Private data may be included where ethically justified, but reproducibility on a public dataset or with an openly described protocol is strongly encouraged.

Submissions may be up to 14 pages (excluding references). Reviews will assess the clarity and soundness of the study design, the appropriateness of metrics and statistical analyses, the transparency of datasets/protocols/code, and the significance for clinical or translational adoption.

Policies

Authorship Policy

• The author list must be final at the time of submission.
• Additions, removals, or order changes after the submission deadline are not permitted (except minor spelling or affiliation corrections approved by the Program Chairs).

Policy on the Use of Large Language Models (LLMs)

MIDL 2026 welcomes the responsible use of modern tools, including Large Language Models (LLMs), when preparing submissions, provided that authors maintain scientific integrity, originality, and full responsibility for all content.

For Authors:

• Permitted uses: LLMs and other assistive tools may be used only for minor language edits, such as grammar, spelling, style refinement, readability improvements, or formatting.
• Prohibited uses: Generating research ideas, study designs, analyses, results, or substantive text with an LLM is not allowed. All scientific contributions must originate from the authors.
• Responsibility: Authors are accountable for the accuracy, originality, and ethical standards of their manuscript, regardless of which tools they used. LLMs may not be credited as authors.
• Data & privacy: Some tools store or reuse text for model training. Authors should avoid entering sensitive or unpublished data into third-party services unless appropriate safeguards are in place.

For Reviewers, Area Chairs, and Program Chairs:

• The review process is confidential. Submissions, code, or supplementary materials must not be shared with LLMs or any external service.
• Reviewers may use public resources or grammar aids to improve clarity, provided no confidential material is exposed.
• Reviewers remain responsible for the accuracy and fairness of their assessments.

General Guidance:

• LLMs must never replace authors’ or reviewers’ critical thinking, due diligence, or validation of references and claims.
• Only humans may be listed as authors, reviewers, or organizers.
• Violations may result in desk rejection, withdrawal after acceptance, or other corrective actions.

Visibility & Publication

• Accepted full papers will be published in the Proceedings of Machine Learning Research (PMLR).
• We encourage authors to share code, models, and datasets to promote open science and reproducibility, although this is not required for acceptance. Please refer to MIDL reproducibility guidelines.

Join us in Taipei, Taiwan, ROC for MIDL 2026 — an inspiring forum to share breakthroughs, exchange ideas, and accelerate the translation of deep learning into biomedical imaging practice.

Submission Timeline

All deadlines are 23:59 UTC-12/Anywhere on Earth (AoE).

Regular Papers

Short Papers

Conference Dates

Contact

Program Chairs: [email protected]

General inquiries: [email protected]